Where do Monopar Therapeutics's ratios come from?

Every ratio is computed from Monopar Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Returns
Return on equity	-15.9%+38.4pp	-14.2%+37.2pp	-26.5%+85.5pp	-59.4%+42.9pp	-54.3%+38.4pp
Return on assets	-15.5%+36.3pp	-13.6%+32.4pp	-25.9%+62.4pp	-56.7%+24.6pp	-51.8%+21.6pp
Efficiency
Asset turnover	0×—	0×—	0×—	0×—	0×—
Liquidity
Current ratio	56×—	——	——	——	——
Quick ratio	56×—	——	——	——	——
Cash ratio	21.4×—	——	——	——	——
Leverage
Debt-to-equity	0×—	0×—	——	——	——
Debt-to-assets	0×—	0×—	——	——	——
Valuation
Market capitalization	$587.04M+192%	$436.37M+225%	$503.9M+2,024%	$203.64M+1,495%	$222.19M+2,095%
Enterprise value	$534.72M+232%	$374.78M—	——	——	——
Price / book	4.3×+0.6×	3.2×+0.7×	3.6×-1.2×	3.9×+1.8×	4.1×+2.8×
Earnings yield	-2.6%+5.7pp	-3.1%+8.5pp	-3.9%+23.4pp	-8.5%+47.3pp	-7.5%+67.7pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where do Monopar Therapeutics's ratios come from?: Every ratio is computed from Monopar Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.